Oral tolerance induction does not resolve gastrointestinal inflammation in a mouse model of food allergy.

SCOPE Oral immunotherapy (OIT) involving continuous oral administration of allergenic foods has gained attention as a therapy for food allergies. To study the influence of oral administration of allergenic foods on gastrointestinal symptoms including inflammation, we established a mouse model of food-induced intestinal allergy. METHODS AND RESULTS BALB/c mice were fed an egg white (EW) diet containing ovalbumin (OVA, a major EW allergen) after intraperitoneal sensitisation with OVA and Alum. The mice on the EW diet for one wk presented gastrointestinal symptoms (i.e. weight loss and soft stools) and inflammation in the small intestines (i.e. duodenum, jejunum and ileum). Further continuous EW diet resolved the weight loss but not the soft stools. Splenic CD4(+) T-cells of EW diet-fed mice on the continuous diet showed less proliferation and cytokine production compared with those of control mice, suggesting tolerance induction by the diet. The continuous EW diet reduced levels of OVA-specific IgE antibodies, but significantly aggravated the inflammation in the jejunum. CONCLUSION Our mouse model would be useful to investigate inflammatory and regulatory mechanisms in food-induced intestinal allergies. Our results suggest potential gastrointestinal inflammation in patients undergoing OIT as continuous administration of allergenic foods, even though the therapy may induce clinical tolerance.

[1]  A. Nowak‐Wegrzyn,et al.  Is oral immunotherapy the cure for food allergies? , 2010, Current opinion in allergy and clinical immunology.

[2]  S. Lira,et al.  A functional role for CCR6 on proallergic T cells in the gastrointestinal tract. , 2010, Gastroenterology.

[3]  Daniel M. Altmann,et al.  Peptide immunotherapy in allergic asthma generates IL-10–dependent immunological tolerance associated with linked epitope suppression , 2009, The Journal of experimental medicine.

[4]  S. Hogan,et al.  Intestinal barrier function: molecular regulation and disease pathogenesis. , 2009, The Journal of allergy and clinical immunology.

[5]  H. Naiki,et al.  Antigen-primed splenic CD8+ T cells impede the development of oral antigen-induced allergic diarrhea. , 2009, The Journal of allergy and clinical immunology.

[6]  I. Kimber,et al.  Animal models of protein allergenicity: potential benefits, pitfalls and challenges , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  M. Moser,et al.  Dendritic Cells Genetically Engineered to Express IL-10 Induce Long-Lasting Antigen-Specific Tolerance in Experimental Asthma1 , 2008, The Journal of Immunology.

[8]  S. Salvatore,et al.  Chronic enteropathy and feeding in children: an update. , 2008, Nutrition.

[9]  A. Burks,et al.  Oral tolerance, food allergy, and immunotherapy: implications for future treatment. , 2008, The Journal of allergy and clinical immunology.

[10]  D. Conrad,et al.  IL-10 Suppresses Mast Cell IgE Receptor Expression and Signaling In Vitro and In Vivo1 , 2008, The Journal of Immunology.

[11]  Colin Summers,et al.  The prevalence of food allergy: a meta-analysis. , 2007, The Journal of allergy and clinical immunology.

[12]  H. Kiyono,et al.  Regulatory role of Peyer's patches for the inhibition of OVA-induced allergic diarrhea. , 2007, Clinical immunology.

[13]  B. Niggemann,et al.  Specific oral tolerance induction in food allergy , 2006, Allergy.

[14]  Y. Kohno,et al.  Food antigen causes TH2-dependent enteropathy followed by tissue repair in T-cell receptor transgenic mice. , 2006, The Journal of allergy and clinical immunology.

[15]  D. Robinson,et al.  Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent , 2005, The Journal of experimental medicine.

[16]  H. Karasuyama,et al.  Ovalbumin-specific IgE modulates ovalbumin-specific T-cell response after repetitive oral antigen administration. , 2005, The Journal of allergy and clinical immunology.

[17]  H. Renz,et al.  Animal models of type I allergy using recombinant allergens. , 2004, Methods.

[18]  R. Wood 37. The Natural History of Food Allergy , 2003 .

[19]  A. Mowat,et al.  Anatomical basis of tolerance and immunity to intestinal antigens , 2003, Nature Reviews Immunology.

[20]  G. Berry,et al.  CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation. , 2002, The Journal of allergy and clinical immunology.

[21]  A. Burks,et al.  A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses. , 2000, The Journal of allergy and clinical immunology.

[22]  K. Foetisch,et al.  Determination of the allergenic activity of birch pollen and apple prick test solutions by measurement of β‐hexosaminidase release from RBL‐2H3 cells. Comparison with classical methods in allergen standardization , 1999, Allergy.

[23]  C. Scudamore,et al.  Mast cell heterogeneity in the gastrointestinal tract: variable expression of mouse mast cell protease-1 (mMCP-1) in intraepithelial mucosal mast cells in nematode-infected and normal BALB/c mice. , 1997, The American journal of pathology.

[24]  M. Goldman,et al.  B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10. , 1994, Journal of immunology.